Selected Natural and Synthetic Agents Effective against Parkinson’s Disease with Diverse Mechanisms
- 1 January 2022
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 22 (3) , 199-208
Abstract
: Similar to other neurodegenerative diseases, Parkinson’s disease (PD) has been extensively investigated with respect to its neuropathological background and possible treatment options. Since the symptomatic outcomes are generally related to dopamine deficiency, the current treatment strate-gies towards PD mainly employ dopaminergic agonists as well as the compounds acting on dopamine metabolism. These drugs do not provide disease modifying properties; therefore alternative drug dis-covery studies focus on targets involved in the progressive neurodegenerative character of PD. This study has aimed to present the pathophysiology of PD concomitant to the representation of drugs and promising molecules displaying activity against the validated and non-validated targets of PD.Keywords
This publication has 115 references indexed in Scilit:
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson diseaseFree Radical Biology and Medicine, 2013
- Role of Oxidative Stress in Parkinson's DiseaseExperimental Neurobiology, 2013
- Effects of Panax ginseng in Neurodegenerative DiseasesJournal of Ginseng Research, 2012
- Investigation of D1Receptor–Agonist Interactions and D1/D2Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology ModelingChemMedChem, 2012
- Amantadine protects dopamine neurons by a dual action: Reducing activation of microglia and inducing expression of GNDF in astrogliaNeuropharmacology, 2011
- Molecular Mechanisms Underlying the Flavonoid-Induced Inhibition of α-Synuclein FibrillationBiochemistry, 2009
- Redox imbalance in Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Levodopa: Past, Present, and FutureEuropean Neurology, 2008
- Mitochondrial translocation of α-synuclein is promoted by intracellular acidificationExperimental Cell Research, 2008
- Cell systems and the toxic mechanism(s) of α-synucleinExperimental Neurology, 2008